Paul Turner is a highly experienced Senior Scientist at Evotec since September 2021, with a strong background in medicinal and synthetic chemistry from previous roles at AstraZeneca. During a nine-year tenure at AstraZeneca Oncology, significant contributions include the invention and first synthesis of AZD6738/ATR and involvement in several successful projects such as AZD0095, AZD4573, and AZD9496. Paul also engaged in innovation and technology advancement, including a two-year secondment to the AZ iLab focusing on automated synthesis and PROTACS development. Earlier career experience includes positions at AstraZeneca and Celltech. Paul holds a Bachelor of Science (BSc) in Applied Chemistry from De Montfort University, earned between 1989 and 1993.
This person is not in any offices